Transcarent, a San Francisco, CA-based healthcare platform supplier, raised $126m in Sequence D funding.
The spherical was led by Common Catalyst and 7wireVentures, joined by new buyers Geodesic Capital and Memorial Hermann Well being System, with help from earlier buyers Threshold Ventures, Kinnevik, Ally Bridge Group, Human Capital, Merck World Well being Innovation Fund, Alta Companions, and Leaps by Bayer.
The corporate intends to make use of the funds to speed up AI capabilities, help industrial development, and strategic development alternatives.
Led by Glen Tullman, Chief Government Officer, and Ken Frazier, Government Chairman, Transcarent is a well being and care platform that makes it simple for folks to entry care and employers to supply and pay for the care. The answer connects Members to complete care experiences together with On a regular basis Care (which incorporates Care in 60 Seconds), Pharmacy Care, Surgical procedure Care (from the nation’s main well being methods, ambulatory care suppliers, and Facilities of Excellence), Weight Well being, and end-to-end Most cancers Care.
For the reason that Sequence C spherical in January 2022, Transcarent has launched complete Weight Well being, Most cancers, Behavioral Well being and Pharmacy Care Experiences along with rising their value-based Surgical procedure Facilities of Excellence program. In 2023, the corporate accomplished the acquisition and integration of the 98point6 AI-powered digital care platform and care enterprise, which incorporates the affiliated Transcarent Clinic. Moreover, Transcarent launched the Nationwide Impartial Supplier Ecosystem with 12 well being methods to ship a high-quality shopper expertise that’s extra inexpensive for self-insured employers.
FinSMEs
02/05/2024
